Trial intelligence / Profile preview

Zero Sodium Peritoneal Dialysate in Human Pilot Study

NCT03801226Phase 1Completed

Sponsor
Yale University
Start
Dec 2018
Primary completion
May 2019
Countries
1
01

Overview

Phase 1, randomised trial of dextrose in heart failure (HF) and Volume overload (2 arms), sponsored by Yale University. Primary endpoint: Protocol discontinuation due to patient discomfort or adverse event at 2 hours. Started Dec 2018; status: completed.

02

Drugs

dextrose
03

Conditions

heart failure (HF)Volume overload

Beyond the preview

Go deeper on NCT03801226.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03801226.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call